Re: Statin Use is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer

被引：0
|
作者：
Taneja, Samir S.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷 / 06期
关键词：
D O I：
10.1097/JU.0000000000001000
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1062 / 1062
页数：1
相关论文
共 50 条
  • [31] Statin use does not reduce the risk of prostate cancer
    Nature Clinical Practice Urology, 2008, 5 (9): : 469 - 469
  • [32] STATIN USE AND RISK OF PROSTATE CANCER IN A POPULATION OF MEN SCREENED FOR PROSTATE CANCER
    Tan, Nelly
    Klein, Eric
    Li, Jianbo
    Moussa, Ayman
    Jones, J. Stephen
    JOURNAL OF UROLOGY, 2011, 185 (04): : E186 - E187
  • [33] Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment
    Qi, Zhi
    Xu, Zihan
    Zhang, Liuzhen
    Zou, Yongkang
    Li, Jinping
    Yan, Wenyu
    Li, Cheng
    Liu, Ningshu
    Wu, Hong
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [34] Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment
    Zhi Qi
    Zihan Xu
    Liuzhen Zhang
    Yongkang Zou
    Jinping Li
    Wenyu Yan
    Cheng Li
    Ningshu Liu
    Hong Wu
    Nature Communications, 13
  • [35] Statin Drug Use is Not Associated with Prostate Cancer Risk in Men Who are Regularly Screened
    Platz, Elizabeth A.
    Tangen, Catherine M.
    Goodman, Phyllis J.
    Till, Cathee
    Parnes, Howard L.
    Figg, William D.
    Albanes, Demetrius
    Neuhouser, Marian L.
    Klein, Eric A.
    Lucia, M. Scott
    Thompson, Ian M., Jr.
    Kristal, Alan R.
    JOURNAL OF UROLOGY, 2014, 192 (02): : 379 - 384
  • [36] A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours
    Sackmann Sala, Lucila
    Boutillon, Florence
    Menara, Giulia
    De Goyon-Pelard, Andrea
    Leprevost, Mylene
    Codzamanian, Julie
    Lister, Natalie
    Pencik, Jan
    Clark, Ashlee
    Cagnard, Nicolas
    Bole-Feysot, Christine
    Moriggl, Richard
    Risbridger, Gail P.
    Taylor, Renea A.
    Kenner, Lukas
    Guidotti, Jacques-Emmanuel
    Goffin, Vincent
    JOURNAL OF PATHOLOGY, 2017, 243 (01): : 51 - 64
  • [37] Curcumin monoglucuronide modulates the tumor microenvironment of Pten-null prostate tumors and exhibits antitumor activity.
    Kura, Yurie
    De Velasco, Marco A.
    Ando, Naomi
    Sakai, Kazuko
    Fujita, Kazutoshi
    Banno, Eri
    Fujita, Yoshihiko
    Hashimoto, Mamoru
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2022, 82 (12)
  • [38] PTP1B deficiency potentiate prostate cancer invasiveness by sensitizing Pten-null tumors to high-fat diet
    Labbe, David P.
    Uetani, Noriko
    Vinette, Valerie
    Aubry, Isabelle
    Migon, Eva
    Sirois, Jacinthe
    Haigh, Jody J.
    Lessard, Laurent
    Begin, Louis R.
    Trotman, Lloyd C.
    Paquet, Marilene
    Tremblay, Michel L.
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [39] PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate
    Chessa, Tamara A. M.
    Jung, Piotr
    Anwar, Arqum
    Suire, Sabine
    Anderson, Karen E.
    Barneda, David
    Kielkowska, Anna
    Sadiq, Barzan A.
    Lai, Ieng Wai
    Felisbino, Sergio
    Turnham, Daniel J.
    Pearson, Helen B.
    Phillips, Wayne A.
    Sasaki, Junko
    Sasaki, Takehiko
    Oxley, David
    Spensberger, Dominik
    Segonds-Pichon, Anne
    Wilson, Michael
    Walker, Simon
    Okkenhaug, Hanneke
    Cosulich, Sabina
    Hawkins, Phillip T.
    Stephens, Len R.
    MOLECULAR CELL, 2023, 83 (16) : 2991 - +
  • [40] Oncogenic signaling in amphiregulin- and EGFR-expressing PTEN-null human breast cancer
    Kappler, Christiana S.
    Guest, Stephen T.
    Smith, Ericka L.
    Irish, Jonathan C.
    Garrett-Mayer, Elizabeth
    Kratche, Zachary
    Ethier, Stephen
    CANCER RESEARCH, 2015, 75
12345